InvestorsHub Logo
Followers 93
Posts 21466
Boards Moderated 0
Alias Born 06/07/2011

Re: 1234jklm post# 108212

Sunday, 12/01/2019 1:31:42 PM

Sunday, December 01, 2019 1:31:42 PM

Post# of 144817
A Smorgasbord of Q&A

You don’t involve eurofins and hidalgo and medscope and hidalgo if you’re not going to file an ind.



Hidalgo is a paid consultant. Eurofins, and Medscape are paid contractors. All are paid for appearance. Kenny doesn't pay a Eurofins or a Hidalgo out of his own pocket. Again again again again again the setup is Kenny sells discounted blocks of shares to a 3rd party for cash up front. Kenny's job is to ensure with his PR pumps the 3rd party can make a nice profit, and comes back for more shares. If retail gets excited over the name of Hidalgo, and it helps Kenny sell blocks of shares, he's more than happy to throw $50K+ to a Hidalgo. And Hidalgo is happy to accept it.

You don’t build a huge state of the art cgmp facility in Bangkok.



Only one problem, AN didn't build anything "huge". It's sort of difficult to build a "huge" biotech manufacturing facility with $2-3M. Might even say it's downright impossible.

First it was the Thai gov, that footed the bill to build the buildings, and assist in providing a clean room infrastructure (e.g. appropriate air flow from the bldg) for any entity that wanted to lease some rooms. In AN's case from all of the wonderful pictures Kenny provided, they apparently have two small room areas for the manufacturing, a small lab outside of the two small rooms. Along with an outer area for a conference room, and entrance room. Neither being able to create a clean room makes anything state of the art.

You don’t go to all the trouble of a master cell bank.



You do for appearances.

This is not like other otc scams. It’s not green tea or Chinese telecoms.



No, not green tea. Instead this scam has a weed (THC) scam angle. Where anything associated with weed is popular in the OTC Market.

This is a real technology that has already worked in dogs. It’s supported by professors like Anne Simpson and doctors like hidalgo and our oncology advisors.



No it's an unreal technology. Where the dog study proved the higher the tumor load, the less a given cancer is likely to respond to a given treatment. Hardly scientific news. Neither could Simpson and Hidalgo care about a faulty canine mammary cancer study.

Of course they’ve been spending funds at Austrianova and eurogins to get it to this stage. Do you think those companies work for free?



They get far less than Kenny, and the BODs get each quarter.

Of course tiny biotechs dilute to get funds.



Microcrap biotech scams dilute with billions of shares. Legit small caps typically are in the range of under 100M, with 1 or more CTs, already in progress, and the cash to fund them fur 2 yrs+. A real biotech sitting on the Nasdaq doesn't dilute itself for 1.3B+ shares, and produce zero in the way of results for 8 yrs. The big kids do not suffer such tactics.

Let the sec investigate this but also acknowledge the technology, team and science.



The SEC does not investigate or pass judgements on claims about science in a scam. They are only interested in investigating whether SEC regulations have been violated or not. PMCB does have problems in how they apparently didn't adhere to the bylaws. They better be careful in the coming Dec 10Q in one area.

Predictions about whether they will submit an ind as just that.



Just as they were when Kenny promised a CT for Q3 2015, and EOY 2016. Which would've been beyond a mere mythical IND.

Nothing the company has announced suggests that they won’t do a trial and be very successful.



They have announced nothing that suggests a mythical CT will be "very successful" in a 2nd line setting.

Maybe they’re making money from selling discount shares and reselling them atm.



3rd parties in the past have done exactly that and have made profit. PMCB has not. And with the Shelf currently frozen, there is no money coming in for Kenny's salary.

But that’s nothing compared to the money they’ll make once ind is accepted and trials start



A legit biotech doesn't make money from a CT. A CT costs money to stage. However, Kenny might profit on nonsense over a filing - assuming he gets the workaround in place for the frozen Shelf.

and the first results come in weeks later.



CTs don't work that way. Assuming PMCB can afford a mythical CT, which they can't currently, the first problem will be patient enrollment. Even with legit treatments for pancreatic cancer, showing dramatic results in previous FDA sanctioned CTs, enrollment can be slow. Past FDA sanctioned CTs don't exist for PMCB. No doubt Kenny would pump out of the kazoo any tumor shrinkage in the only patient to be recruited "weeks later". Which is meaningless. At last check the proposed endpt was PFS. Which would be followed for close to a year only if it worked. Expected based on the difficulties of treating 2nd line patients, plus the history of the use of Ifosfamide, for such purposes, the Kenny Wonder Treatment will fail, having reached median PFS, at 3 months.

Surgically precise tumour shrinkage without side effects.



There is nothing "Surgically precise" about Chemo. Provide a link which gives the amount of Ifosfamide converted in the human body by locally implanted CIABs - there is no such link. Provide a link that shows the presence of CIABs make any difference when Metronomic Ifosfamide is administered - there is none. Therefore, any claims made by Kenny about CIABs are unproven. There will be side effects due to the Ifosfamide. These include neutropenia, as a result of bone marrow suppression, bladder inflammation, unless Mensa is given (as Lohr did), and neurological toxicity.

We know the chemo works.



No we do not. In fact, a more developed thicker stromal layer in 2nd line patients (if any patients enroll) is extremely difficult to treat. Past results using Ifosfamide at 1.2 gms/m2 gave a 3 month PFS in 2nd line, along with neurological effects. The lower 1 gm/m2 is likely to have the same or less effect.

We know kw is just doing the company side and is a mouthpiece for gunzburg and salmons.



Finally a point of agreement. Yes Gunzburg&Salmons helped setup the PMCB scam for the purpose of infusing cash into their company AN. It was all legal in its setup. Then they brought in Kenny to PR pump the stock. Since Kenny had prior P&D scam experience.

When this is shown to work kw will make more from selling his shares than from any dilution



Then poor Kenny, because it will not work. However, maybe one of his PR pumps will work in the future, so he can dump? As a 1933 filer, he can dump at any time without filing a Form 4. In fact he gets 300K of stock to dump every month. A continuing resupply from year to year.

And the 3s and that wall are just where we are now. Do you think anyone will be selling at 4 when the ind is announced?



First it's highly unlikely the IND submission will not be announced. Again...if Kenny ever submits the mythical IND asking for a Phase 2b it will be rejected. If he submits the mythical IND as a Phase 1, it has a 40:60 chance of getting approved by the FDA. Which is better than zero percent chance. Then maybe Kenny can PR pump a short spike of a few pennies, before it goes back down. How fast, it goes up/down depends on how many more shares are being held by 3rd parties waiting to be dumped. Potential for retail traders to benefit - assuming the huge dump doesn't bury traders. One thing for sure, is recent paid promos, haven't resulted in 1.3B+ shares being bid up, and supported by retail. If Kenny wants to follow through on his charade of the mythical CT, he'll need to dilute hundreds of millions of shares more. All discounted to 3rd parties of course. Then the question becomes: If retail can't current bid up, and support the current O/S of 1.3B+, how will they do so with 2B+ in the future? Dilution in Microcrap stocks is never a problem, until after it happens.

The Jewel of the Mind is Colored with the Hue of what it Imagines

Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent PMCB News